SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker.

Zadora, J; Singh, M; Herse, F; Przybyl, L; Haase, N; Golic, M; Yung, HW; Huppertz, B; Cartwright, JE; Whitley, GS; et al. Zadora, J; Singh, M; Herse, F; Przybyl, L; Haase, N; Golic, M; Yung, HW; Huppertz, B; Cartwright, JE; Whitley, GS; Johnsen, GM; Levi, G; Isbruch, A; Schulz, H; Luft, FC; Müller, DN; Staff, AC; Hurst, LD; Dechend, R; Izsvák, Z (2017) Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker. Circulation, 136 (19). pp. 1824-1839. ISSN 1524-4539 https://doi.org/10.1161/CIRCULATIONAHA.117.028110
SGUL Authors: Cartwright, Judith Eleanor

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (8MB) | Preview

Abstract

Background -Preeclampsia (PE) is a complex and common human-specific pregnancy syndrome associated with placental pathology. The human-specificity provides both intellectual and methodological challenges, lacking a robust model system. Given the role of imprinted genes in human placentation and the vulnerability of imprinted genes to loss of imprinting changes, there has been extensive speculation, but no robust evidence, that imprinted genes are involved in PE. Our study aims at investigating whether disturbed imprinting contributes to PE. Methods -We first aimed at confirming that PE is a disease of the placenta by generating and analysing genome-wide molecular data on well-characterized patient material. We performed high-throughput transcriptome analyses of multiple placenta samples from normal and PE patients. Next, we identified differentially expressed genes (DEGs) in PE placenta, and intersected them with the list of human imprinted genes. We employed bioinformatics/statistical analyses to confirm association between imprinting and PE, and to predict biological processes affected in PE. Validation included epigenetic and cellular assays. Regarding human-specificity, we established an in vitro invasion-differentiation trophoblast model. Our comparative phylogenetic analysis involved single-cell transcriptome data of human, macaque and mouse preimplantation embryogenesis. Results -We found disturbed placental imprinting in PE and revealed potential candidates, including GATA3 and DLX5, with poorly explored imprinted status and no prior association with PE. Due to loss of imprinting DLX5 was upregulated in 69% of PE placentas. Levels of DLX5 correlated with classical PE marker. DLX5 is expressed in human, but not in murine trophoblast. The DLX5(high) phenotype resulted in reduced proliferation, increased metabolism and ER stress-response activation in trophoblasts in vitro The transcriptional profile of such cells mimics the transcriptome of PE placentas. Pan-mammalian comparative analysis identified DLX5 as a part of the human-specific regulatory network of trophoblast differentiation. Conclusions -Our analysis provides evidence of a true association between disturbed imprinting, gene expression and PE. Due to disturbed imprinting, the upregulated DLX5 affects trophoblast proliferation. Our in vitro model might fill a vital niche in PE research. Human-specific regulatory circuitry of DLX5 might help to explain certain aspects of PE.

Item Type: Article
Additional Information: This is a non-final version of an article published in final form in Zadora, J; Singh, M; Herse, F; Przybyl, L; Haase, N; Golic, M; Yung, HW; Huppertz, B; Cartwright, JE; Whitley, GS; et al. (2017) Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker. Circulation. 2017;136:1824-1839
Keywords: ER stress, Genomic imprinting, Trophoblast, epigenetics, genome-wide analysis, preeclampsia/pregnancy, ER stress, Genomic imprinting, Trophoblast, epigenetics, genome-wide analysis, preeclampsia/pregnancy, Cardiovascular System & Hematology, 1103 Clinical Sciences, 1102 Cardiovascular Medicine And Haematology, 1117 Public Health And Health Services
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Vascular (INCCVA)
Journal or Publication Title: Circulation
ISSN: 1524-4539
Language: eng
Dates:
DateEvent
7 November 2017Published
13 September 2017Published Online
28 August 2017Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
HE 6249/1-2Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
HE 6249/4-1Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
DE 631/9-1Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
UNSPECIFIEDGerman Centre for Cardiovascular ResearchUNSPECIFIED
084804/2/08/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
ERC-2011-AdG 294742European Research Councilhttp://dx.doi.org/10.13039/501100000781
PubMed ID: 28904069
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109197
Publisher's version: https://doi.org/10.1161/CIRCULATIONAHA.117.028110

Actions (login required)

Edit Item Edit Item